Topic
Latest reporting and analysis tagged with Fred Alger Management.
Fred Alger Management released its Q4 2025 investor letter for the Alger Small Cap Focus Fund, noting market trends and discussing stock performance, including details on Stevanato Group.
Fred Alger Management's Alger Spectra Fund released its Q4 2025 investor letter, noting the fund underperformed the Russell 3000 Growth Index. The letter highlighted Microsoft's stock performance and provided commentary on its cloud business and capital expenditure plans.
Fred Alger Management's Alger Spectra Fund released its Q4 2025 investor letter, noting the fund underperformed the Russell 3000 Growth Index. The letter cited Meta Platforms as a leading detractor due to investor concerns over AI-related capital expenditure guidance.
Fred Alger Management's Alger Weatherbie Specialized Fund released its Q4 2025 investor letter, noting underperformance against the Russell 2500 Growth Index and detailing its commentary on holding FirstService Corporation.
Fred Alger Management's Small Cap Focus Fund outperformed the Russell 2000 Growth Index in Q4 2025, with Guardant Health highlighted as a key holding after strong quarterly results.
Fred Alger Management's Small Cap Focus Fund outperformed the Russell 2000 Growth Index in Q4 2025, with Utilities and Financials sectors contributing positively. The fund highlighted Natera, Inc. in its investor letter.
Fred Alger Management's Alger Small Cap Focus Fund outperformed the Russell 2000 Growth Index in Q4 2025, with Utilities and Financials sectors contributing positively. The fund highlighted Nebius Group as a key holding.
Fred Alger Management released its Q4 2025 investor letter for the Alger Small Cap Focus Fund, noting market gains and sector performance. The fund highlighted UniQure N.V., detailing stock volatility and FDA feedback on its gene therapy.